Angion Biomedica Corp. (ANGN)

AI Score

Unlock

1.00

0.00 (0.00%)

At close: Jun 01, 2023, 8:00 PM

Angion Biomedica Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	14.84M	21.68M	29.22M	50.49M	55.14M	63.37M	73M	88.76M	102.74M	117.31M	130.46M	34.61M	19.11M	5.57M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	150K	874K	874K	865K	732K	723K	862K	843K	877K	822K	1.05M	999K
Other Long-Term Assets	3.52M	3.52M	864K	61K	75K	86K	78K	106K	33K	38K	38K	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	807K	440K
Inventory	n/a	n/a	1.02M	392K	1.2M	2.05M	2.76M	-1.67M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.09M	4.54M	11.41M	943K	1.54M	2.51M	3.24M	2.49M	1.66M	2.39M	3.04M	7.69M	2.41M	95K
Total Current Assets	19.93M	26.23M	40.63M	51.43M	56.68M	65.89M	76.24M	91.25M	104.39M	119.7M	133.5M	42.3M	22.33M	6.11M
Property-Plant & Equipment	7.54M	7.87M	126K	425K	3.69M	3.98M	4.21M	4.44M	4.65M	4.78M	4.79M	4.23M	4.36M	4.78M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	11.06M	11.39M	1.14M	1.36M	4.64M	4.93M	5.02M	5.27M	5.55M	5.66M	5.7M	5.05M	5.41M	5.78M
Total Assets	30.99M	37.62M	41.77M	52.79M	61.32M	70.81M	81.26M	96.51M	109.94M	125.36M	139.2M	47.35M	27.74M	11.89M
Account Payables	4.41M	4.26M	692K	2.72M	2.22M	2.66M	3.43M	4.71M	7.68M	9.31M	6.69M	5.58M	4.65M	11.24M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	4.09M	653K	2.3M	3.66M	5.18M	3.79M	3.94M	n/a	n/a
Short-Term Debt	938K	985K	227K	1.06M	1.03M	1M	978K	894K	870K	847K	1.68M	52.04M	852K	6.88M
Other Current Liabilities	6.14M	2.35M	1.11M	2.59M	4.93M	4.12M	5.32M	3.39M	5.74M	5.19M	4.81M	45.89M	4.87M	8.46M
Total Current Liabilities	11.49M	7.6M	2.03M	6.37M	8.18M	7.78M	10.38M	11.3M	17.95M	20.52M	16.96M	107.45M	10.37M	26.57M
Long-Term Debt	6.21M	6.42M	70K	2.65M	2.92M	3.19M	3.46M	3.48M	3.71M	3.93M	4.15M	4.48M	4.64M	3.9M
Other Long-Term Liabilities	n/a	46K	n/a	n/a	n/a	81K	220K	235K	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	6.21M	6.46M	70K	2.65M	2.92M	3.27M	3.67M	3.71M	27.48M	27.65M	29.79M	30.35M	4.64M	3.9M
Total Liabilities	17.7M	14.06M	2.1M	9.02M	11.11M	11.05M	14.06M	15.01M	45.43M	48.17M	46.76M	137.8M	15.01M	30.47M
Total Debt	7.15M	7.4M	297K	3.71M	3.96M	4.2M	4.43M	4.37M	4.58M	4.78M	5.83M	56.52M	5.49M	10.78M
Common Stock	84K	84K	301K	301K	301K	301K	300K	300K	304K	303K	300K	156K	223K	148K
Retained Earnings	-133.25M	-122.6M	-258.48M	-253.94M	-247.5M	-238.51M	-229.38M	-215.13M	-230.03M	-214.32M	-197.25M	-160.56M	-132.81M	-80.45M
Comprehensive Income	-25K	-2K	165K	86K	302K	98K	-199K	-103K	-73K	-219K	-287K	-333K	-65K	n/a
Shareholders Equity	13.29M	23.56M	39.67M	43.77M	50.21M	59.76M	67.2M	81.51M	64.51M	77.19M	92.44M	-90.45M	12.73M	-18.59M
Total Investments	n/a	n/a	150K	874K	874K	865K	732K	723K	862K	843K	877K	822K	1.05M	999K